A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Por Ziemssen, Tjalf, Bajenaru, Ovidiu A., Carrá, Adriana, de Klippel, Nina, de Sá, João C., Edland, Astrid, Frederiksen, Jette L., Heinzlef, Olivier, Karageorgiou, Klimentini E., Lander Delgado, Rafael H., Landtblom, Anne-Marie, Macías Islas, Miguel A., Tubridy, Niall, Gilgun-Sherki, Yossi
Publicado no J Neurol (2014)

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIM...

Por Ziemssen, Tjalf, Bajenaru, Ovidiu A., Carrá, Adriana, de Klippel, Nina, Correia de Sá, João, Edland, Astrid, Frederiksen, Jette L., Heinzlef, Olivier, Karageorgiou, Klimentini E., Lander Delgado, Rafael H., Landtblom, Anne-Marie, Macías Islas, Miguel A., Tubridy, Niall, Gilgun-Sherki, Yossi
Publicado no J Neurol (2014)

Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial

Por Cambron, Melissa, Mostert, Jop, Haentjens, Patrick, D’Hooghe, Marie, Nagels, Guy, Willekens, Barbara, Heersema, Dorothea, Debruyne, Jan, Van Hecke, Wim, Algoed, Luc, De Klippel, Nina, Fosselle, Erwin, Laureys, Guy, Merckx, Henri, Van Wijmeersch, Bart, Vanopdenbosch, Ludo, Verhagen, Wim, Hupperts, Raymond, Hengstman, Gerald, Michiels, Veronique, Van Merhaegen-Wieleman, Annick, De Keyser, Jacques
Publicado em 2014